Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamatergic Modulation on Cocaine Self-administration
NCT02596022Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Jun 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ketamine in cocaine dependence, sponsored by New York State Psychiatric Institute. Started Jun 2013; status: completed.
02
Drugs
ketamine
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT02596022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02596022.